SCHEMBL30962724

SCHEMBL30962724

COc1nc(Cl)ncc1C(=O)Nc1c(F)ccc(F)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 8/20 0.44
▸ ATF1 P18846 5/20 0.44
▸ PDE4D Q08499 3/20 0.43
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ JUN P05412 3/20 0.41
▸ NFKB2 Q00653 3/20 0.41
▸ RELA Q04206 3/20 0.41
▸ HPGD P15428 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ XPO1 O14980 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962625 0.84 PDE4D (0.47) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962910 0.81 NFKB1 (0.47) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962730 0.81 POLB (0.46) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962863 0.79 NFKB1 (0.42) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962894 0.77 CHRNA7 (0.48) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962881 0.77 NFKB1 (0.48) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962582 0.76 CHRNA7 (0.41) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962627 0.75 PDE4A (0.43) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962815 0.74 CHRNA7 (0.40) NFKB1ATF1PDE4DPDE4APDE4B
SCHEMBL30962872 0.74 NFKB1 (0.39) NFKB1ATF1PDE4DPDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback